Article Text

Extended report
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis
  1. Paul A Lyons1,
  2. Eoin F McKinney1,
  3. Tim F Rayner1,
  4. Alexander Hatton1,
  5. Hayley B Woffendin1,
  6. Maria Koukoulaki1,
  7. Thomas C Freeman2,
  8. David R W Jayne1,
  9. Afzal N Chaudhry1,
  10. Kenneth G C Smith1
  1. 1Cambridge Institute for Medical Research and Department of Medicine, Addenbrooke's Hospital, Cambridge, UK
  2. 2Roslin Institute, University of Edinburgh, Roslin, Midlothian, UK
  1. Correspondence to Dr Paul Lyons or Professor Ken Smith, Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK; pal34{at}cam.ac.uk or kgcs2{at}cam.ac.uk

Abstract

Objective To optimise a strategy for identifying gene expression signatures differentiating systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibody-associated vasculitis that provide insight into disease pathogenesis and identify biomarkers.

Methods 44 vasculitis patients, 13 SLE patients and 25 age and sex-matched controls were enrolled. CD4 and CD8 T cells, B cells, monocytes and neutrophils were isolated from each patient and, together with unseparated peripheral blood mononuclear cells (PBMC), were hybridised to spotted oligonucleotide microarrays.

Results Using expression data obtained from purified cells a substantial number of differentially expressed genes were identified that were not detectable in the analysis of PBMC. Analysis of purified T cells identified a SLE-associated, CD4 T-cell signature consistent with type 1 interferon signalling driving the generation and survival of tissue homing T cells and thereby contributing to disease pathogenesis. Moreover, hierarchical clustering using expression data from purified monocytes provided significantly improved discrimination between the patient groups than that obtained using PBMC data, presumably because the differentially expressed genes reflect genuine differences in processes underlying disease pathogenesis.

Conclusion Analysis of leucocyte subsets enabled the identification of gene signatures of both pathogenic relevance and with better disease discrimination than those identified in PBMC. This approach thus provides substantial advantages in the search for diagnostic and prognostic biomarkers in autoimmune disease.

This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

Footnotes

  • Funding The study received financial support from the NIHR Cambridge Biomedical Research Centre, the Wellcome Trust, Kidney Research UK, the Medical Research Council and the Evelyn Trust. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Cambridge Local Research Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.